We’ve all been more aware of lung health since Covid-19.
However, for people with asthma and chronic obstructive pulmonary disease (COPD), dealing with lung problems is a lifelong struggle. Those with COPD suffer from highly inflamed lung tissue that swells and obstructs airways, making it hard to breathe. The disease is common, with more than three million annual cases in the US alone.
Although manageable, there is no cure. One problem is that lungs with COPD pump out tons of viscous mucus, which forms a barrier preventing treatments from reaching lung cells. The slimy substance—when not coughed out—also attracts bacteria, further aggravating the condition.
A new study in Science Advances describes a potential solution. Scientists have developed a nanocarrier to shuttle antibiotics into the lungs. Like a biological spaceship, the carrier has “doors” that open and release antibiotics inside the mucus layer to fight infections.
The “doors” themselves are also deadly. Made from a small protein, they rip apart bacterial membranes and clean up their DNA to rid lung cells of chronic infection.
The team engineered an inhalable version of an antibiotic using the nanocarrier. In a mouse model of COPD, the treatment revived their lung cells in just three days. Their blood oxygen levels returned to normal, and previous signs of lung damage slowly healed.
“This immunoantibacterial strategy may shift the current paradigm of COPD management,” the team wrote in the article.
Breathe Me
Lungs are extremely delicate. Picture thin but flexible layers of cells separated into lobes to help coordinate oxygen flow into the body. Once air flows through the windpipe, it rapidly disperses among a complex network of branches, filling thousands of air sacs that supply the body with oxygen while ridding it of carbon dioxide.
These structures are easily damaged, and smoking is a common trigger. Cigarette smoke causes surrounding cells to pump out a slimy substance that obstructs the airway and coats air sacs, making it difficult for them to function normally.
In time, the mucus builds a sort of “glue” that attracts bacteria and condenses into a biofilm. The barrier further blocks oxygen exchange and changes the lung’s environment into one favorable for bacteria growth.
One way to stop the downward spiral is to obliterate the bacteria. Broad-spectrum antibiotics are the most widely used treatment. But because of the slimy protective layer, they can’t easily reach bacteria deep inside lung tissues. Even worse, long-term treatment increases the chance of antibiotic resistance, making it even more difficult to wipe out stubborn bacteria.
But the protective layer has a weakness: It’s just a little bit too sour. Literally.
Open-Door Policy
Like a lemon, the slimy layer is slightly more acidic compared to healthy lung tissue. This quirk gave the team an idea for an ideal antibiotic carrier that would only release its payload in an acidic environment.
The team made hollow nanoparticles out of silica—a flexible biomaterial—filled them with a common antibiotic, and added “doors” to release the drugs.
These openings are controlled by additional short protein sequences that work like “locks.” In normal airway and lung environments, they fold up at the door, essentially sequestering the antibiotics inside the bubble.
Released in lungs with COPD, the local acidity changes the structure of the lock protein, so the doors open and release antibiotics directly into the mucus and biofilm—essentially breaking through the bacterial defenses and targeting them on their home turf.
One test with the concoction penetrated a lab-grown biofilm in a petri dish. It was far more effective compared to a previous type of nanoparticle, largely because the carrier’s doors opened once inside the biofilm—in other nanoparticles, the antibiotics remained trapped.
The carriers could also dig deeper into infected areas. Cells have electrical charges. The carrier and mucus both have negative charges, which—like similarly charged ends of two magnets—push the carriers deeper into and through the mucus and biofilm layers.
Along the way, the acidity of the mucus slowly changes the carrier’s charge to positive, so that once past the biofilm, the “lock” mechanism opens and releases medication.
The team also tested the nanoparticle’s ability to obliterate bacteria. In a dish, they wiped out multiple common types of infectious bacteria and destroyed their biofilms. The treatment appeared relatively safe. Tests in human fetal lung cells in a dish found minimal signs of toxicity.
Surprisingly, the carrier itself could also destroy bacteria. Inside an acidic environment, its positive charge broke down bacterial membranes. Like popped balloons, the bugs released genetic material into their surroundings, which the carrier swept up.
Damping the Fire
Bacterial infections in the lungs attract overactive immune cells, which leads to swelling. Blood vessels surrounding air sacs also become permeable, making it easier for dangerous molecules to get through. These changes cause inflammation, making it hard to breathe.
In a mouse model of COPD, the inhalable nanoparticle treatment quieted the overactive immune system. Multiple types of immune cells returned to a healthy level of activation—allowing the mice to switch from a highly inflammatory profile to one that combats infections and inflammation.
Mice treated with the inhalable nanoparticle had about 98 percent less bacteria in their lungs, compared to those given the same antibiotic without the carrier.
Wiping out bacteria gave the mice a sigh of relief. They breathed easier. Their blood oxygen levels went up, and blood acidity—a sign of dangerously low oxygen—returned to normal.
Under the microscope, treated lungs restored normal structures, with sturdier air sacks that slowly recovered from COPD damage. The treated mice also had less swelling in their lungs from fluid buildup that’s commonly seen in lung injuries.
The results, while promising, are only for a smoking-related COPD model in mice. There’s still much we don’t know about the treatment’s long-term consequences.
Although for now there were no signs of side effects, it’s possible the nanoparticles could accumulate inside the lungs over time eventually causing damage. And though the carrier itself damages bacterial membranes, the therapy mostly relies on the encapsulated antibiotic. With antibiotic resistance on the rise, some drugs are already losing effect for COPD.
Then there’s the chance of mechanical damage over time. Repeatedly inhaling silicon-based nanoparticles could cause lung scarring in the long term. So, while nanoparticles could shift strategies for COPD management, it’s clear we need follow-up studies, the team wrote.
Image Credit:

News
Unlocking hidden soil microbes for new antibiotics
Most bacteria cannot be cultured in the lab-and that's been bad news for medicine. Many of our frontline antibiotics originated from microbes, yet as antibiotic resistance spreads and drug pipelines run dry, the soil [...]
By working together, cells can extend their senses beyond their direct environment
The story of the princess and the pea evokes an image of a highly sensitive young royal woman so refined, she can sense a pea under a stack of mattresses. When it comes to [...]
Overworked Brain Cells May Hold the Key to Parkinson’s
Scientists at Gladstone Institutes uncovered a surprising reason why dopamine-producing neurons, crucial for smooth body movements, die in Parkinson’s disease. In mice, when these neurons were kept overactive for weeks, they began to falter, [...]
Old tires find new life: Rubber particles strengthen superhydrophobic coatings against corrosion
Development of highly robust superhydrophobic anti-corrosion coating using recycled tire rubber particles. Superhydrophobic materials offer a strategy for developing marine anti-corrosion materials due to their low solid-liquid contact area and low surface energy. However, [...]
This implant could soon allow you to read minds
Mind reading: Long a science fiction fantasy, today an increasingly concrete scientific goal. Researchers at Stanford University have succeeded in decoding internal language in real time thanks to a brain implant and artificial intelligence. [...]
A New Weapon Against Cancer: Cold Plasma Destroys Hidden Tumor Cells
Cold plasma penetrates deep into tumors and attacks cancer cells. Short-lived molecules were identified as key drivers. Scientists at the Leibniz Institute for Plasma Science and Technology (INP), working with colleagues from Greifswald University Hospital and [...]
This Common Sleep Aid May Also Protect Your Brain From Alzheimer’s
Lemborexant and similar sleep medications show potential for treating tau-related disorders, including Alzheimer’s disease. New research from Washington University School of Medicine in St. Louis shows that a commonly used sleep medication can restore normal sleep patterns and [...]
Sugar-Coated Nanoparticles Boost Cancer Drug Efficacy
A team of researchers at the University of Mississippi has discovered that coating cancer treatment carrying nanoparticles in a sugar-like material increases their treatment efficacy. They reported their findings in Advanced Healthcare Materials. Over a tenth of breast [...]
Nanoparticle-Based Vaccine Shows Promise in Fighting Cancer
In a study published in OncoImmunology, researchers from the German Cancer Research Center and Heidelberg University have created a therapeutic vaccine that mobilizes the immune system to target cancer cells. The researchers demonstrated that virus peptides combined [...]
Quantitative imaging method reveals how cells rapidly sort and transport lipids
Lipids are difficult to detect with light microscopy. Using a new chemical labeling strategy, a Dresden-based team led by André Nadler at the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) and [...]
Ancient DNA reveals cause of world’s first recorded pandemic
Scientists have confirmed that the Justinian Plague, the world’s first recorded pandemic, was caused by Yersinia pestis, the same bacterium behind the Black Death. Dating back some 1,500 years and long described in historical texts but [...]
“AI Is Not Intelligent at All” – Expert Warns of Worldwide Threat to Human Dignity
Opaque AI systems risk undermining human rights and dignity. Global cooperation is needed to ensure protection. The rise of artificial intelligence (AI) has changed how people interact, but it also poses a global risk to human [...]
Nanomotors: Where Are They Now?
First introduced in 2004, nanomotors have steadily advanced from a scientific curiosity to a practical technology with wide-ranging applications. This article explores the key developments, recent innovations, and major uses of nanomotors today. A [...]
Study Finds 95% of Tested Beers Contain Toxic “Forever Chemicals”
Researchers found PFAS in 95% of tested beers, with the highest levels linked to contaminated local water sources. Per- and polyfluoroalkyl substances (PFAS), better known as forever chemicals, are gaining notoriety for their ability [...]
Long COVID Symptoms Are Closer To A Stroke Or Parkinson’s Disease Than Fatigue
When most people get sick with COVID-19 today, they think of it as a brief illness, similar to a cold. However, for a large number of people, the illness doesn't end there. The World [...]
The world’s first AI Hospital, developed in China is transforming healthcare
Artificial Intelligence and its developments have had a revolutionary impact on society, and healthcare is not an exception. China has made massive strides in AI integrated healthcare, and continues to do so as AI [...]